Probiotic pill may cut Kids' sore throat episodes
NCT ID NCT07235826
First seen Nov 19, 2025 · Last updated Jun 23, 2026 · Updated 30 times
Summary
This study tests whether a daily probiotic tablet called Bactoblis Evol can reduce how often children aged 3 to 11 get tonsillitis. Two hundred children with a history of at least three episodes in the past year will take either the probiotic or a placebo for three months, then switch. Researchers will track episodes, antibiotic use, and school absences.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT TONSILLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Università di Urbino Carlo Bo
RECRUITINGUrbino, PU (Pesaro E Urbino), 61029, Italy
Contact Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Streptococcus salivarius Evol12 probiotic
What this could lead to
If it works, this could offer a simple, daily probiotic to help children have fewer and shorter tonsillitis episodes, reducing the need for antibiotics or surgery.
What could go wrong
This is a small, early-stage trial with only 200 children. The effect may be small or no better than placebo, and results may not apply to all children.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.